Advertisement
Research Article| Volume 17, ISSUE 3, P367-378, September 1997

Download started.

Ok

The Clinical Utility of Antihistone Antibodies

Autoantibodies Reactive with Chromatin in Systemic Lupus Erythematosus and Drug-Induced Lupus
DOI:https://doi.org/10.1016/S0272-2712(18)30201-4
The Clinical Utility of Antihistone Antibodies
Previous ArticleEnzyme Immunoassays for Antinuclear Antibodies
Next ArticleRole of Autoantibody Tests in the Diagnostic Evaluation of Neuropsychiatric Systemic Lupus Erythematosus
      This paper is only available as a PDF. To read, Please Download here.
      Autoantibodies reactive with denatured histones and with epitopes requiring the native histone-DNA structure in chromatin have been measured by many techniques. The presence of antichromatin antibodies is useful in diagnosing systemic lupus erythematosus and in diagnosing lupus induced by procainamide and certain other drugs such as quinidine, isoniazid, sulfasalazine and acebutolol. In contrast, antibodies to denatured histones do not appear to be diagnostically useful at this time.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Agnello V.
        • Arbeiter A.
        • De Kasep G.I.
        • et al.
        Evidence for a subset of rheumatoid factors that cross-react with DNA-histone and have a distinct cross-idiotype.
        J Exp Med. 1980; 151: 1514-1527
        • Arents G.
        • Burlingame R.W.
        • Wang B.-C.
        • et al.
        The nucleosomal core histone octamer at 3.1 A resolution: A tripartite protein assembly and a left-handed superhelix.
        Proc Natl Acad Sei USA. 1991; 88: 10148-10152
        • Berden J.H.M.
        • Smeenk R.J.T.
        Nucleosome-specific autoantibodies.
        in: Peter J.B. Shoenfeld Y. Autoantibodies. Elsevier Science, New York1996: 574-581
        • Bray V.J.
        • West S.G.
        • Schultz K.T.
        • et al.
        Antihistone antibody profile in sulfasalazine induced lupus.
        J Rheumatol. 1994; 21: 2157-2158
        • Burlingame R.W.
        • Boey M.L.
        • Starkebaum G.
        • et al.
        The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.
        J Clin Invest. 1994; 94: 184-192
        • Burlingame R.W.
        • Rubin R.L.
        Drug-induced anti-histone autoantibodies display two patterns of reactivity with substructures of chromatin.
        J Clin Invest. 1991; 88: 680-690
        • Burlingame R.W.
        • Rubin R.L.
        Anti-histone autoantibodies recognize centromeric heterochromatin in metaphase chromosomes and hidden epitopes in interphase cells.
        Hum Antibodies Hybridomas. 1992; 3: 40-47

      8. Burlingame RW, Rubin RL: Histones. In van Venrooij WJ, Maini RN (eds): Manual of Biological Markers of Disease, Section B: The Autoantigens. Dordrecht, The Netherlands, Kluwer Academic Publishers Group, 1994, pp B2.2/1-B2.2/18

        • Burlingame R.W.
        • Rubin R.L.
        • Balderas R.S.
        • et al.
        Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen.
        J Clin Invest. 1993; 91: 1687-1696
        • Burlingame R.W.
        • Rubin R.L.
        • Rosenberg A.M.
        Autoantibodies to chromatin components in juvenile rheumatoid arthritis.
        Arthritis Rheum. 1993; 36: 836-841
        • Chabre H.
        • Amoura Z.
        • Piette J.-C.
        • et al.
        Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus.
        Arthritis Rheum. 1995; 38: 1485-1491
        • Chou M.J.
        • Lee S.L.
        • Chen T.Y.
        • et al.
        Specificity of antinuclear antibodies in primary biliary cirrhosis.
        Ann Rheum Dis. 1995; 54: 148-151
        • Cohen A.S.
        • Reynolds W.E.
        • Franklin E.C.
        • et al.
        Preliminary criteria for the classification of systemic lupus erythematosus.
        Bull Rheum Dis. 1971; 21: 643-648
        • Cohen M.G.
        • Kevat S.
        • Prowse M.V.
        • et al.
        Two distinct quinidine-induced rheumatic syndromes.
        Ann Intern Med. 1988; 108: 369-371
        • Costa O.
        • Monier J.C.
        Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis.
        J Rheumatol. 1986; 13: 722-725
        • Craft J.E.
        • Radding J.A.
        • Harding M.W.
        • et al.
        Autoantigenic epitopes: A comparison between procainamide and hydralazine-induced lupus.
        Arthritis Rheum. 1987; 30: 689-694
        • Czaja A.J.
        • Ming C.
        • Shirai M.
        • et al.
        Frequency and significance of antibodies to histones in autoimmune hepatitis.
        J Hepatol. 1995; 23: 32-38
        • Eickbush T.H.
        • Moudrianakis E.N.
        The histone core complex: An octamer assembled by two sets of protein-protein interactions.
        Biochemistry. 1978; 17: 4955-4964
        • Enzenauer R.J.
        • West S.G.
        • Rubin R.L.
        D-penicillamine-induced lupus erythematosus [see comments].
        Arthritis Rheum. 1990; 33: 1582-1585
        • Fritzler M.J.
        Drugs recently associated with lupus syndromes [review].
        Lupus. 1994; 3: 455-459
        • Fritzler M.J.
        • Tan E.M.
        Antibodies to histones in drug-induced and idiopathic lupus erythematosus.
        J Clin Invest. 1978; 62: 560-567
        • Gohill J.
        • Cary P.D.
        • Couppez M.
        • et al.
        Antibodies from patients with drug-induced lupus and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histones.
        J Immunol. 1985; 135: 3116-3121
        • Halbert S.P.
        • Karsh J.
        • Anken M.
        Studies on autoantibodies to deoxyribonucleic acid and deoxyribonucleoprotein with enzyme-immunoassay (ELISA).
        J Lab Clin Med. 1981; 97: 97-111
        • Hamburger R.N.
        Induction of the lupus erythematosus ("L.E.") cell in vitro in peripheral blood.
        Yale J Biol Med. 1950; 22: 407-410
        • Hardin J.A.
        • Thomas J.O.
        Antibodies to histones in systemic lupus erythematosus: Localization of prominent autoantigens on histones HI and H2B.
        Proc Natl Acad Sei USA. 1983; 80: 7410-7414
        • Hargraves M.M.
        • Richmond H.
        • Morton R.J.
        Presentation of two bone marrow elements, 'Tart" cell and "L.E." cell.
        Mayo Clin Proc. 1948; 23: 25-28
        • Haynes D.C.
        • Gershwin M.E.
        • Robbins D.L.
        • et al.
        Autoantibody profiles in juvenile arthritis.
        J Rheumatol. 1986; 13: 358-363
        • Holman H.R.
        • Deicher H.R.
        The reaction of the lupus erythematosus (LE) cell factor with deoxyribonucleoprotein of the cell nucleus.
        J Clin Invest. 1959; 38: 2059-2072
        • Jacob L.
        • Viard J.P.
        Anti-DNA antibodies and their relationships with anti-histone and anti-nucleosome specificities [review].
        Eur J Med. 1992; 1: 425-431
        • Kaliyaperumal A.
        • Mohan C.
        • Wu W.
        • et al.
        Nucleosomal peptide epitopes for nephritis- inducing T helper cells of murine lupus.
        J Exp Med. 1996; 183: 2459-2469
        • Kamei M.
        • Kato M.
        • Mochizuki K.
        • et al.
        Serodiagnosis of cancers by ELISA of antihistone H2B antibody.
        Biotherapy. 1992; 4: 17-22
        • Karsh J.
        • Halbert S.P.
        • Anken M.
        • et al.
        Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjogren's syndrome and rheumatoid arthritis.
        Int Arch Allergy Appl Immunol. 1982; 68: 60-69
        • Kono D.H.
        • Burlingame R.W.
        • Kuramachi A.
        • et al.
        Lupus susceptibility loci in New Zealand mice.
        Proc Natl Acad Sei USA. 1994; 91: 10168-10172
        • Kramers C.
        • Hylkema M.N.
        • van Brüggen M.C.
        • et al.
        Anti-nucleosome antibodies com- plexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.
        J Clin Invest. 1994; 94: 568-577
        • Kretz-Rommel A.
        • Duncan S.R.
        • Rubin R.L.
        Autoimmunity caused by disruption of central T-cell tolerance: A murine model of drug-induced lupus.
        J Clin Invest. 1997; 99: 1888-1896
        • Lachmann P.J.
        An attempt to characterize the lupus erythematosus cell antigen.
        Immunology. 1961; 4: 153-163
        • Lefkowith J.B.
        • Gilkeson G.S.
        Nephritogenic autoantibodies in lupus: Current concepts and continuing controversies [review].
        Arthritis Rheum. 1996; 39: 894-903
        • Lefkowith J.B.
        • Kiehl M.
        • Rubenstein J.
        • et al.
        Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus.
        J Clin Invest. 1996; 98: 1373-1380
        • Lutter L.C.
        Kinetic analysis of deoxyribonuclease I cleavages in the nucleosome core: Evidence for a DNA superhelix.
        J Mol Biol. 1978; 124: 391-420
        • Martin L.
        • Pauls J.D.
        • Ryan J.P.
        • et al.
        Identification of a subset of patients with scleroderma with severe pulmonary and vascular disease by the presence of autoantibodies to centromere and histone [see comments].
        Ann Rheum Dis. 1993; 52: 780-784
        • Massa M.
        • De Benedetti F.
        • Pignatti P.
        • et al.
        Anti-double stranded DNA, anti-histone, and anti-nucleosome IgG reactivities in children with systemic lupus erythematosus.
        Clin Exp Rheumatol. 1994; 12: 219-225
        • Massa M.
        • De Benedetti F.
        • Pignatti P.
        • et al.
        Lack of temporal association of iridocyclitis with IgG reactivities to core histones and nucleosome subparticles in pauciarticular juvenile chronic arthritis.
        Br J Rheumatol. 1995; 34: 507-511
        • Mecocci P.
        • Ekman R.
        • Parnetti L.
        • et al.
        Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia.
        Biological Psychiatry. 1993; 34: 380-385
        • Mencke A.J.
        • Rill R.L.
        Circular dichroism and thermal denaturation studies of subnucleo- somes and their relationships to nucleosome structure.
        Biochemistry. 1982; 21: 4362-4370
        • Moens U.
        • Seternes O.M.
        • Hey A.W.
        • et al.
        In vivo expression of a single viral DNA- binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones.
        Proc Natl Acad Sei USA. 1995; 92: 12393-12397
        • Mongey A.B.
        • Donovan-Brand R.
        • Thomas T.J.
        • et al.
        Serologic evaluation of patients receiving procainamide [see comments].
        Arthritis Rheum. 1992; 35: 219-223
        • Morel L.
        • Yu Y.
        • Blenman K.R.
        • et al.
        Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain.
        Mammalian Genome. 1996; 7: 335-339
        • Nordstrom D.M.
        • West S.G.
        • Rubin R.L.
        Methyldopa-induced systemic lupus erythematosus.
        Arthritis Rheum. 1989; 32: 205-208
        • Ostensen M.
        • Fredriksen K.
        • Kass E.
        • et al.
        Identification of antihistone antibodies in subsets of juvenile chronic arthritis.
        Ann Rheum Dis. 1989; 48: 114-117
        • Pisetsky D.S.
        • Grudier J.P.
        • Gilkeson G.S.
        A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus.
        Arthritis Rheum. 1990; 33: 153-159
        • Plaué S.
        • Muller S.
        • Van Regenmortel M.H.V.
        A branched, synthetic octapeptide of ubiquitinated histone H2A as target of autoantibodies.
        J Exp Med. 1989; 169: 1607-1616
        • Portanova J.P.
        • Arndt R.E.
        • Tan E.M.
        • et al.
        Anti-histone antibodies in idiopathic and drug- induced lupus recognize distinct intrahistone regions.
        J Immunol. 1987; 138: 446-451
        • Rekvig O.P.
        • Hannestad K.
        Lupus erythematosus (LE) factors recognize both nucleo- somes and viable human leukocytes.
        Scand J Immunol. 1981; 13: 597-604
        • Richmond T.J.
        • Finch J.T.
        • Rushton B.
        • et al.
        Structure of the nucleosome core particle at 7A resolution.
        Nature (Lond). 1984; 311: 532-537
        • Rubin R.L.
        Autoimmune reactions induced by procainamide and hydralazine.
        in: Kammuller M. Bloksma M. Sieman W. Autoimmunity and Toxicology: Immune Disregulation Induced by Drugs and Chemicals. Elsevier, Amsterdam1988: 119-150
        • Rubin R.L.
        Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs.
        Clin Biochem. 1992; 25: 223-234
        • Rubin R.L.
        • Bell S.A.
        • Burlingame R.W.
        Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex.
        J Clin Invest. 1992; 90: 165-173
        • Rubin R.L.
        • Burlingame R.W.
        • Arnott J.E.
        • et al.
        IgG but not other classes of anti-[(H2A- H2B)-DNA] is an early sign of procainamide-induced lupus.
        J Immunol. 1995; 154: 2483-2493
        • Rumore P.
        • Muralidhar B.
        • Lin M.
        • et al.
        Haemodialysis as a model for studying endogenous plasma DNA: Oligonucleosome-like structure and clearance.
        Clin Exp Immunol. 1992; 90: 56-62
        • Salazar-Paramo M.
        • Rubin R.L.
        • Garcia-De La Torre I.
        Systemic lupus erythematosus induced by isoniazid.
        Ann Rheum Dis. 1992; 51: 1085-1087
        • Sato S.
        • Ihn H.
        • Soma Y.
        • et al.
        Antihistone antibodies in patients with localized scleroderma.
        Arthritis Rheum. 1993; 36: 1137-1141
        • Stemmer C.
        • Muller S.
        Histone autoantibodies other than (H2A-H2B)-DNA autoantibodies.
        in: Peter J.B. Shoenfeld Y. Elsevier Science, New York1996: 373-384
        • Suzuki T.
        • Burlingame R.W.
        • Casiano C.A.
        • et al.
        Antihistone antibodies in systemic lupus erythematosus: Assay dependency and effects of ubiquitination and serum DNA.
        J Rheumatol. 1994; 21: 1081-1091
        • Tan E.M.
        • Cohen A.S.
        • Fries J.F.
        • et al.
        The 1982 revised criteria for the classification of systemic lupus erythematosus.
        Arthritis Rheum. 1982; 25: 1271-1277
        • Thomas J.O.
        • Wilson C.M.
        • Hardin J.A.
        The major core histone antigenic determinants in systemic lupus erythematosus are in the trypsin sensitive regions.
        FEBS Lett. 1984; 169: 90-96
        • Vazquez-Del Mercado M.
        • Casiano C.A.
        • Rubin R.L.
        IgA antihistone antibodies in isonia- zid-treated tuberculosis patients.
        Autoimmunity. 1995; 20: 105-111
        • Wallace D.J.
        • Lin H.C.
        • Shen G.Q.
        • et al.
        Antibodies to histone (H2A-H2B)-DNA complexes in the absence of antibodies to double-stranded DNA or to (H2A-H2B) complexes are more sensitive and specific for scleroderma-related disorders than for lupus.
        Arthritis Rheum. 1994; 37: 1795-1797
        • Zamber R.W.
        • Starkebaum G.
        • Rubin R.L.
        • et al.
        Drug induced systemic lupus erythematosus due to ophthalmic timolol [see comments].
        J Rheumatol. 1992; 19: 977-979

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30201-4

      Copyright

      © 1997 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX